AI-electrocardiogram model developed to diagnose liver disease earlier

As rates of obesity, high blood pressure, type 2 diabetes and sleep apnea increase, cases of advanced chronic liver disease ...
Seeking Alpha

Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress

CONSHOHOCKEN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated ...

Liver Cirrhosis Competitive Landscape 2025: Insights Into 30+ Companies and 30+ Emerging Therapies Driving EMA, PDMA & FDA Advancements, DelveInsight Analysis

In June 2024, Resolution Therapeutics, in collaboration with the University of Edinburgh, presented pivotal RTX001 data at ...
Medscape

Effective Strategies for Managing Late-Stage Primary Biliary Cirrhosis?

The disease affects mainly middle-aged women between the ages of 35 and 60 but can affect all ages and races. At least 30% of patients are initially asymptomatic. The diagnosis is usually made during ...
Business Insider

Yaqrit appoints new CEO Troels Jordansen to implement late clinical development and commercial strategy

Experienced private and public listed CEO Successful fund raising and business development track record New CEO available during JPM25 in San Francisco LONDON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Yaqrit ...
Seeking Alpha

Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024

Cirrhosis is an end stage liver disease of varying etiologies such as alcoholic liver disease, chronic viral hepatitis, nonalcoholic fatty liver disease and primary cholangitis. Complications of ...